癌变·畸变·突变 ›› 2005, Vol. 17 ›› Issue (1): 45-47.doi: 10.3969/j.issn.1004-616x.2005.01.015

• 论著 • 上一篇    下一篇

乳腺癌细胞对八种抗癌药物的化疗敏感性

喻卫红;蔡玉娥;孟凡娟;李艳萍;逯晓波   

  1. 辽宁省肿瘤研究所临床肿瘤研究室, 辽宁 沈阳 110042
  • 收稿日期:2004-05-26 修回日期:2004-05-28 出版日期:2005-01-30 发布日期:2005-01-30
  • 通讯作者: 喻卫红

Chemosensitivity of Eight Anti-cancer Drugs on Breast Cancer Cells

YU Wei-hong;CAI Yu-e;MENG Fan-juan;et al   

  1. Department of Clinical Oncology, Liaoning Province Tumor Institute, Shenyang 110042,China
  • Received:2004-05-26 Revised:2004-05-28 Online:2005-01-30 Published:2005-01-30
  • Contact: YU Wei-hong

摘要: 背景与目的:本文研究了不同个体乳腺癌细胞对八种抗癌药物的化疗敏感性。材料与方法: 根据临床血浆高峰浓度(1 PPC),41例乳腺癌细胞受8种抗癌药物分别作用48 h,采用MTT法的肿瘤细胞抑制率分析了化疗敏感性。 结果: 在临床血浆高峰浓度(1 PPC)和细胞数为1×105/孔的条件下,乳腺癌细胞的平均抑制率(%)为表柔芘星(EADM)44.30±13.40和米托蒽醌(MTZ)44.14±13.46,其化疗敏感性比其它药物较高,但无统计学意义。8种抗癌药物在肿瘤临床分期和病理分型、淋巴结转移时的化疗敏感性差异有显著性。 结论: 41例乳腺癌细胞对8种抗癌药物有不同的化疗敏感性。体外MTT法对不同个体乳腺癌进行化疗敏感性预测是必要的。

关键词: 抗癌药物, 乳腺癌, 化疗敏感性

Abstract: BACKGROUND & AIM: To investigate the chemosensitivity of eight anti-cancer drugs in breast cancer cells of different individual. MATERIAL AND METHODS: The breast cancer cells from 41 patients were being exposed to eight anti-cancer drugs for 48 h, at concentration according to 1 plasma peak concentration(1 PPC). The inhibition rate of tumor cells was used in vitro MTT assay to determine chemosensitivity. RESULTS: At amount of 1×105 tumor cells/perwell in the present of 1 PPC, the breast cancer cells had higher chemosensitivity to the EADM, MTZ treatment with the inhibition rate of (44.30±10.66) %, (44.14±13.05) % than other of drugs, and but they were of no significant. A statistically significant difference was P<0.01,P<0.05 and P<0.05 in chemosensitivity of eight drugs between clinical stages,pathology types and lymphoid metastasis. CONCLUSION: Eight anti-cancer drugs had a difference chemosensitivity to the breast cancer cells from 41 patients. The In vitro MTT assay was essential for predicting chemosensitivity of individual breast cancer patients.

Key words: anti-cancer drug, breast cancer, chemosensitivity